Cargando…
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
The phospholipase A2 receptor (PLA2R1) is the major autoantigen in idiopathic membranous nephropathy (MN). However, the pathogenic role of anti-PLA2R1 autoantibodies is unclear. Our aim was to evaluate the in vitro cytotoxicity of anti-PLA2R1 antibodies mediated by complement. Forty-eight patients w...
Autores principales: | Lateb, Maël, Ouahmi, Hajar, Payré, Christine, Brglez, Vesna, Zorzi, Kevin, Dolla, Guillaume, Zaidan, Mohamad, Boyer-Suavet, Sonia, Knebelmann, Bertrand, Crépin, Thomas, Courivaud, Cécile, Jourde-Chiche, Noémie, Esnault, Vincent, Lambeau, Gérard, Seitz-Polski, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012209/ https://www.ncbi.nlm.nih.gov/pubmed/32083137 http://dx.doi.org/10.1155/2019/1324804 |
Ejemplares similares
-
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020) -
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021) -
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020) -
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021) -
Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)